The euphoria over the US-China trade truce began to fade as investors digested the latest reading on consumer prices.

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

CVS Health posted impressive Q1 2025 results with jumps in revenue, net income, and sales, yet it still decided to rain on ...

The Growth Distillery in collaboration with Ogilvy and Kantar, has released new research into the evolving dynamics of influence within the health sector. The Influence Codes: The Chemistry of ...

AC Health, the health care arm of conglomerate Ayala Corp. (AC), is aiming to be a $2-billion health care enterprise by 2035. "What started as a bold ambition to build a connected health care system ...

Nutritional inequality, particularly among women and children, represents one of the most critical public health challenges in India today. Despite significant strides in economic growth and ...

Other health insurers took a hit after UHG's dismal announcement, including CVS Health (shares fell 8.5 percent in the immediate aftermath) and Humana (shares fell 16 percent). But things appear ...

With new leadership in place, a 4% dividend yield and trough earnings behind us, we see continued attractive prospects ahead. We added to CVS Health Corp ... to multiple AI growth engines ...

"Organic growth in advance of the hub being completed remains strong, with One Health Group continuing to perform well over the second half of the financial year, well ahead of last year, and setting ...

South Asia’s growth prospects have weakened, with projections downgraded in most countries in the region. Stepping up domestic revenue mobilisation could help the region strengthen fragile ...

The fund cautioned that if countries fail to "urgently resolve" their trade tensions, it could further damage their growth prospects. "If sustained, this abrupt increase in tariffs and attendant ...